SeaStar Medical Holding Corp. (ICU): Price and Financial Metrics

SeaStar Medical Holding Corp. (ICU): $0.71

0.00 (-0.25%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

D

ICU Price/Volume Stats

Current price $0.71 52-week high $2.31
Prev. close $0.71 52-week low $0.16
Day low $0.65 Volume 975,682
Day high $0.72 Avg. volume 5,465,727
50-day MA $0.82 Dividend yield N/A
200-day MA $0.59 Market Cap 39.05M

ICU Stock Price Chart Interactive Chart >



ICU Latest News Stream


Event/Time News Detail
Loading, please wait...

ICU Latest Social Stream


Loading social stream, please wait...

View Full ICU Social Stream

Latest ICU News From Around the Web

Below are the latest news stories about SEASTAR MEDICAL HOLDING CORP that investors may wish to consider to help them evaluate ICU as an investment opportunity.

SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury

DENVER, Dec. 28, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces enrollment of 12 subjects in the NEUTRALIZE-AKI pivotal clinical trial evaluating the safety and efficacy of its patented, first-in-class, cell-directed Selective Cytopheretic Device (SCD) extracorporeal therapy in critically ill adults with acute kidney injury (AKI) requir

Yahoo | December 28, 2023

SeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical Experts

DENVER, Dec. 13, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of dysregulated immune responses including hyperinflammation on vital organs, announces the formation of the SeaStar Medical Scientific Advisory Board (SAB). The SAB is comprised of world-renowned international pediatric and adult clinical experts including nephrologists, critical care intensivists and translational scie

Yahoo | December 13, 2023

SeaStar Medical files for $100M mixed shelf

More on SeaStar Medical Holding Corporation

SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update

DENVER, Nov. 14, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, reports financial results for the three and nine months ended September 30, 2023 and provides a business update. “Recent clinical and regulatory successes have significantly improved and strengthened our company’s prospects,” said Eric Schlorff, S

Yahoo | November 14, 2023

Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device

MINNEAPOLIS, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced its strategic partner, SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical), received an Approvable Letter from the U.S. Food and Drug Administration (FDA) for its pediatric Selective Cytopheretic Device (SCD-PED). The SCD-PED will provide a new therapy option for children weighing 10 kilograms o

Yahoo | October 31, 2023

Read More 'ICU' Stories Here

ICU Price Returns

1-mo -13.20%
3-mo 18.33%
6-mo -30.39%
1-year -67.36%
3-year -92.85%
5-year N/A
YTD 60.38%
2023 -89.20%
2022 -59.16%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!